Roswell Park to Test Investigational Brain Cancer Vaccine in Phase I…

Peptide vaccine targets cancer survival protein, putting tumor cells in Catch 22

(PRWeb September 27, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog